Wed, 04th Nov 2020 20:19
GlaxoSmithKline PLC - FTSE 100-listed pharmaceutical company - Says ViiV Healthcare Chief Executive Deborah Waterhouse sold 21,828 shares at a price of 1,346.10 pence each on Tuesday. Transaction worth GBP293,827. ViiV Healthcare is majority owned by GSK, with Pfizer Inc and Shionogi Ltd as shareholders.
Current stock price: 1,415.00 pence
Year-to-date change: down 20%
By Lucy Heming; lucyheming@alliancenews.com
Copyright 2020 Alliance News Limited. All Rights Reserved.
GSK PLC - London-based pharmaceuticals firm - Senior Vice President, Global Communications & Chief Executive Office, Sally Jackson, buys 1,120 shares ...
(Sharecast News) - London stocks remained in negative territory by Friday's close, although they managed to recoup some of the losses seen earlier in ...
(Alliance News) - Stock prices in London were lacklustre at midday on Friday, as investors eye the trajectory of interest rates across the globe.
(Alliance News) - GSK PLC on Friday said it has sold its remaining shares in Haleon PLC, marking a total exit from its consumer healthcare spin-off.
(Alliance News) - Stock prices in London opened lower on Friday, after Thursday saw Wall Street's rally end in a record breaking session.
Glaxosmithkline (GSK)